Issue Date | Title | Author(s) |
2017-05-01 | The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription. | Wong, M; Tee, AEL; Milazzo, G; Bell, JL; Poulos, RC; Atmadibrata, B; Sun, Y; Jing, D; Ho, N; Ling, D; Liu, PY; Zhang, XD; Hüttelmaier, S; Wong, JWH; Wang, J; Polly, P; Perini, G; Scarlett, CJ; Liu, T |
2021 | Fusion imaging-guided radiofrequency ablation for residual hepatocellular carcinoma invisible on ultrasound after transcatheter arterial chemoembolization. | Gu, J-H; Zhao, Q-Y; He, C; Ye, Z-D; Xu, M; Jiang, T-A |
2022-10-12 | Extracellular vesicles from biological fluids as potential markers in castration resistant prostate cancer. | Choi, WWY; Sánchez, C; Li, JJ; Dinarvand, M; Adomat, H; Ghaffari, M; Khoja, L; Vafaee, F; Joshua, AM; Chi, KN; Guns, EST; Hosseini-Beheshti, E |
2018-04-01 | The first clinical implementation of real-time image-guided adaptive radiotherapy using a standard linear accelerator | Keall, PJ; Nguyen, DT; O'Brien, R; Caillet, V; Hewson, E; Poulsen, PR; Bromley, R; Bell, L; Eade, T; Kneebone, A; Martin, J; Booth, JT |
2009-10-20 | Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer | Arndt, GM; Dossey, L; Cullen, LM; Lai, A; Druker, R; Eisbacher, M; Zhang, C; Tran, N; Fan, H; Retzlaff, K; Bittner, A; Raponi, M |
2021-11 | Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: Implications for clinical practice. | Oey, O; Ghaffari, M; Li, JJ; Hosseini-Beheshti, E |
2011-06-01 | Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome) | Roberts, A; Nancarrow, D; Clendenning, M; Buchanan, DD; Jenkins, MA; Duggan, D; Taverna, D; McKeone, D; Walters, R; Walsh, MD; Young, BW; Jass, JR; Rosty, C; Gattas, M; Pelzer, E; Hopper, JL; Goldblatt, J; George, J; Suthers, GK; Phillips, K; Parry, S; Woodall, S; Arnold, J; Tucker, K; Muir, A; Drini, M; MacRae, F; Newcomb, P; Potter, JD; Pavluk, E; Lindblom, A; Young, JP |
2022-05-03 | Activation of the viral sensor oligoadenylate synthetase 2 (Oas2) prevents pregnancy-driven mammary cancer metastases. | Ho, W-HJ; Law, AMK; Masle-Farquhar, E; Castillo, LE; Mawson, A; O'Bryan, MK; Goodnow, CC; Gallego-Ortega, D; Oakes, SR; Ormandy, CJ |
2018-05-01 | Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial | Porceddu, SV; Bressel, M; Poulsen, MG; Stoneley, A; Veness, MJ; Kenny, LM; Wratten, C; Corry, J; Cooper, S; Fogarty, GB; Collins, M; Collins, MK; Macann, AMJ; Milross, CG; Penniment, MG; Liu, HYH; King, MT; Panizza, BJ; Rischin, D |
2016-01-07 | ELF5 isoform expression is tissue-specific and significantly altered in cancer. | Piggin, CL; Roden, DL; Gallego-Ortega, D; Lee, HJ; Oakes, SR; Ormandy, CJ |